PubMed for id: 81825

Year	Number of Results
1996	1
1998	3
1999	4
2001	6
2002	8
2003	7
2004	16
2005	22
2006	27
2007	38
2008	33
2009	56
2010	51
2011	53
2012	54
2013	35
2014	2
2024	0

1

Argonaute-1 functions as a mitotic regulator by controlling Cyclin B during Drosophila early embryogenesis.

Pushpavalli SN, Sarkar A, Bag I, Hunt CR, Ramaiah MJ, Pandita TK, Bhadra U, Pal-Bhadra M. Pushpavalli SN, et al. FASEB J. 2014 Feb;28(2):655-66. doi: 10.1096/fj.13-231167. Epub 2013 Oct 28. FASEB J. 2014. PMID: 24165481 Free PMC article.

2

In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference.

Kandeel M, Kitade Y. Kandeel M, et al. J Comput Aided Mol Des. 2013 Jul;27(7):605-14. doi: 10.1007/s10822-013-9665-3. Epub 2013 Jul 23. J Comput Aided Mol Des. 2013. PMID: 23877830

3

Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates.

Karginov FV, Hannon GJ. Karginov FV, et al. Genes Dev. 2013 Jul 15;27(14):1624-32. doi: 10.1101/gad.215939.113. Epub 2013 Jul 3. Genes Dev. 2013. PMID: 23824327 Free PMC article.

4

Highly complementary target RNAs promote release of guide RNAs from human Argonaute2.

De N, Young L, Lau PW, Meisner NC, Morrissey DV, MacRae IJ. De N, et al. Mol Cell. 2013 May 9;50(3):344-55. doi: 10.1016/j.molcel.2013.04.001. Mol Cell. 2013. PMID: 23664376 Free PMC article.

5

Argonaute2 expression is post-transcriptionally coupled to microRNA abundance.

Martinez NJ, Gregory RI. Martinez NJ, et al. RNA. 2013 May;19(5):605-12. doi: 10.1261/rna.036434.112. Epub 2013 Mar 13. RNA. 2013. PMID: 23485552 Free PMC article.

6

Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray.

Wang YX, Zhang XY, Zhang BF, Yang CQ, Gao HJ. Wang YX, et al. Int J Clin Exp Pathol. 2013;6(3):476-84. Epub 2013 Feb 15. Int J Clin Exp Pathol. 2013. PMID: 23411422 Free PMC article.

7

T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire.

Bronevetsky Y, Villarino AV, Eisley CJ, Barbeau R, Barczak AJ, Heinz GA, Kremmer E, Heissmeyer V, McManus MT, Erle DJ, Rao A, Ansel KM. Bronevetsky Y, et al. J Exp Med. 2013 Feb 11;210(2):417-32. doi: 10.1084/jem.20111717. Epub 2013 Feb 4. J Exp Med. 2013. PMID: 23382546 Free PMC article.

8

Argonaute2 regulates the pancreatic β-cell secretome.

Tattikota SG, Sury MD, Rathjen T, Wessels HH, Pandey AK, You X, Becker C, Chen W, Selbach M, Poy MN. Tattikota SG, et al. Mol Cell Proteomics. 2013 May;12(5):1214-25. doi: 10.1074/mcp.M112.024786. Epub 2013 Jan 28. Mol Cell Proteomics. 2013. PMID: 23358505 Free PMC article.

9

The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.

Deleavey GF, Frank F, Hassler M, Wisnovsky S, Nagar B, Damha MJ. Deleavey GF, et al. Nucleic Acid Ther. 2013 Feb;23(1):81-7. doi: 10.1089/nat.2012.0393. Epub 2013 Jan 5. Nucleic Acid Ther. 2013. PMID: 23289589

10

Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.

Cheng N, Li Y, Han ZG. Cheng N, et al. Hepatology. 2013 May;57(5):1906-18. doi: 10.1002/hep.26202. Hepatology. 2013. PMID: 23258480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

388 results

Results by year